This is an automatically translated article.
Eskafoxime is indicated for the treatment of upper respiratory tract infections, acute community-acquired pneumonia, uncomplicated acute gonococcal infection and urinary tract infections...Let's find out the necessary information about the treatment. Use the drug Eskafoxim through the article below.
1. What is Eskafoxime?
Drug name: Eskafoxim Dosage form: Capsule. Packing: 4 blisters x 4 tablets/box. Ingredients: Cefpodoxime proxetil 100mg. Manufacturer: Eskayef Bangladesh - Bangladesh.
2. Uses of the drug Eskafoxime
2.1 Indications Eskafoxime is indicated for the treatment of:
Upper respiratory tract infections such as sinusitis, tonsillitis, acute otitis media and pharyngitis; Community acute pneumonia; Acute gonococcal infection; Urinary tract infections; Skin and skin structure infections. 2.2 Dosage - How to take Eskafoxim The dosage of Eskafoxim is as follows:
For adults:
Upper respiratory tract infections, tonsillitis and pharyngitis: 100mg every 12 hours for 10 days. Community-acquired pneumonia: 200mg every 12 hours for 14 days. Acute gonococcal infection: 200mg single dose. Urinary tract infections: 100mg every 12 hours for 7 days. Skin and tissue structure infections: 400mg every 12 hours for 7-14 days. For children:
Acute otitis media: 10 mg/kg/day, for 10 days (maximum 400 mg/day in 2 divided doses). Pharyngitis/tonsillitis: 10mg/kg/day (maximum 200mg/day in 2 divided doses) for 10 days. In patients with renal impairment with creatinine clearance less than 30 ml/min, the interval between doses should be increased to 24 hours. Cirrhotic patients: No dose adjustment is required. How to use: Eskafoxime is taken orally, with meals.
2.3 Overdose When an overdose of Eskafoxim is taken, nausea, vomiting, epigastric pain and diarrhea may occur. In the event of a severe toxic reaction, hemodialysis or peritoneal dialysis can help remove cefpodoxime from the body, especially in patients with impaired renal function.
3. Contraindications of the drug Eskafoxim
Eskafoxime is contraindicated in people with a history of hypersensitivity to cefpodoxime proxetil.
4. Notes/ Precautions when using Eskafoxim
Warning :
Before starting treatment with cefpodoxime proxetil, the patient should be determined to have a hypersensitivity reaction to cefpodoxime, other cephalosporins and penicillins. Use caution when administering cefpodoxime to penicillin-sensitive patients. Because cross-sensitivity between beta-lactam antibiotics has been well demonstrated in patients with a history of penicillin allergy (may occur in up to 10%). Pseudomembranous colitis has been reported with nearly all antibacterial agents including cefpodoxime, and can range in severity from mild to severe. Therefore, caution should be exercised when using Eskafoxim in this subject. Treatment with broad-spectrum antibiotics, including cefpodoxime proxetil, may alter the normal flora of the large intestine and may promote overgrowth of closiridia. Caution:
In patients with transient or persistent oliguria due to renal impairment, the total daily dose of cefpodoxime proxetil should be reduced. Cefpodoxime should be used with caution in patients treated concomitantly with potent diuretics. Long-term use of cefpodoxime is not recommended because it may lead to overgrowth of non-susceptible organisms. Where superinfection occurs during treatment, appropriate measures should be taken. For pregnant women:
Did not show any teratogenic or fetotoxic effects (studies have been conducted in many laboratory animals). Cefpodoxime can be used during pregnancy only if clearly needed. Lactation:
Cefpodoxime is excreted in breast milk. Because of the potential for serious reactions in a nursing infant, a decision should be made whether to discontinue the drug or to discontinue nursing. Consider the important benefits of Eskafoxim to the mother.
5. Eskafoxime side effects
Eskafoxime can cause some mild and transient side effects such as: Diarrhea, nausea, vomiting, abdominal pain, colitis and headache. Eskafoxim has rarely caused hypersensitivity reactions, rash, pruritus, dizziness, thrombocytopenia, thrombocytopenia, leukopenia or eosinophilia. If you experience these symptoms, the patient should stop using Eskafoxim and notify the doctor for appropriate treatment.
Above is the entire information about the drug Eskafoxim, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Eskafoxime at home because there may be unwanted side effects.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
